...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Respiratory viruses in adult liver transplant recipients.
【24h】

Respiratory viruses in adult liver transplant recipients.

机译:成人肝移植受者中的呼吸道病毒。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The contribution of respiratory viruses to respiratory disease in adult liver transplant (LT) recipients has not been studied. We performed a prospective audit to document the incidence of respiratory syncytial viruses ([RSVs], parainfluenza virus, influenza virus, and adenovirus) after LT, and to determine their contribution to respiratory disease in this setting. METHODS: Consecutive adult recipients were followed for 8 months after LT. Throat swabs were collected weekly for up to 12 weeks after LT, and virological surveillance was performed using conventional techniques (direct immunofluorescence and cell culture). A polymerase chain reaction assay for RSV was subsequently performed on selected specimens. Clinical data, including episodes of respiratory disease, were also recorded. RESULTS: During the study period, 51 patients received 53 LT. Five patients died, but no viruses were isolated from these patients at any stage. A total of 323 swabs were examined by conventional techniques and yielded 35 viral isolates (10.8%). Herpes simplex virus (type 1) accounted for 33 isolates, none of which were associated with respiratory disease. Two of 323 swabs (0.62%), in 2 patients, yielded respiratory viruses (both RSV); both patients had self-limiting, mild, upper respiratory tract symptoms. In these 2 patients, the polymerase chain reaction assay was more sensitive than conventional techniques and was able to detect extended RSV excretion. Of 51 recipients, 31 (61%) were always negative for viruses. Of 51 recipients, 10 developed respiratory failure, but no respiratory viruses were isolated from any of these patients. CONCLUSIONS: Respiratory viruses are rarely isolated from adult recipients after LT and are not associated with serious morbidity or with mortality. Routine surveillance for respiratory viruses in this patient population is not justified on the basis of this study.
机译:背景:在成人肝移植(LT)接受者中呼吸道病毒对呼吸道疾病的贡献尚未得到研究。我们进行了一项前瞻性审核,以记录LT后呼吸道合胞病毒([RSV],副流感病毒,流感病毒和腺病毒)的发生率,并确定在这种情况下它们对呼吸道疾病的贡献。方法:连续性成年人接受LT后8个月。 LT后长达12周每周收集一次咽拭子,并使用常规技术(直接免疫荧光和细胞培养)进行病毒学监测。随后在选定的标本上进行RSV的聚合酶链反应测定。还记录了包括呼吸系统疾病发作在内的临床数据。结果:在研究期间,有51名患者接受了53例LT。五名患者死亡,但在任何阶段均未从这些患者中分离出病毒。通过常规技术检查了总共323个拭子,并产生了35个病毒分离株(占10.8%)。单纯疱疹病毒(1型)占33株,其中没有一例与呼吸系统疾病有关。在2例患者中,有323支拭子中有2支(0.62%)产生了呼吸道病毒(均为RSV);两名患者均出现自限性轻度上呼吸道症状。在这2例患者中,聚合酶链反应测定法比常规技术更灵敏,并且能够检测到RSV排泄延长。在51位收件人中,有31位(61%)始终对病毒阴性。在51位接受者中,有10位发生了呼吸衰竭,但没有从这些患者中分离出任何呼吸道病毒。结论:LT患者术后很少从成人受体中分离出呼吸道病毒,并且与严重的发病率或死亡率无关。在这项研究的基础上,常规监测呼吸道病毒在该患者人群中是不合理的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号